Search 

We are industry leaders in strategy and solutions

Triad knows you are looking to collect as much information as you can about your competitors.  One of our favorite Sun Tzu quotes is “If you know the enemy and know yourself, you need not fear the result of a hundred battles.”  This is particularly fitting for competitive intelligence.  In order to be as strategic as possible, we encourage our clients to take stock of their own potential. We then work with them to figure out what questions we really need to answer about their competition, to make a difference in their future planning.  When you ask a question, you should know what you will do with the answer.

Triad views our process as highly interactive. We want to communicate with you throughout the project, so that as intelligence is gathered, it can be processed and redirected. Key Intelligence Topics get revisited regularly to make sure we are asking the best questions to the most knowledgeable sources.

With a well-designed research plan, a diverse contact list, and highly skilled analysts, Triad will confidently present you with the most insightful intelligence attainable. Since the process includes mapping out your strategy early on, our reports can deliver concise and actionable findings to help you and your team put your brand on the right path forward.

Trillium Medical Center is a South Florida based medical facility specializing in Internal Medicine.  The center has facilities to diagnose and treat Internal Medical problems.  By providing our patients with state of the art Preventative, Acute, and Chronic treatment options we are able to help patients lose weight safely, maintain healthy diet regimens and life styles, and ensure their health conditions are monitored on a regular basis. 

By extending our capabilities to provide 24 hour/365 Day access to patient's health records, each patient can gain access to their important and vital medical information no matter where they travel or which physician they visit, even if it is not at our center.  

We also offer a variety of "In House" tertiary services including an in house Med Spa complete with Esthetic services including Botox, Juvederm, Microdermabrasion and other wellness treatments like Weight Management and Nutrition training.

Trillium Medical Ventures LLC, a bio science technology assessment firm founded in 1998, evaluates life science intellectual property and technology with the objective of identifying unique and valuable life science investment and product development opportunities. Trillium has extensive experience in the identification and analysis of biopharmaceutical and pharmaceutical intellectual-property licensing opportunities at all stages of the drug-development cycle, from basic research to regional and worldwide clinical development. The Team is made up of pharmaceutically-trained life science professionals with decades of industry experience encompassing drug discovery and product development, life sciences start-up investing and intellectual property evaluation. The Trillium Team’s experience in life sciences truly spans from the “research bench to the pharmacy shelf” and allows us to provide expert services.

UMass Amherst, the Commonwealth's flagship campus, is a nationally ranked public research university offering a full range of undergraduate, graduate and professional degrees.

In 2007, the university opened a 22,000 square foot Research Building that focuses on science and houses the Botulinum Research Center. The building, the first at UMass Dartmouth devoted entirely to research, strengthens an "Innovation Triangle" in southeastern Massachusetts that includes major research and development centers in New Bedford and Fall River.

UAlbany students choose from 120 undergraduate majors and minors and more than 125 graduate programs. Many of these programs are nationally ranked, among them criminal justice, information and technology management (Informatics), public administration, social welfare, public health andsociology. 

In every area of study, students are instructed by faculty who are world-class scholars and teachers - many actively engaged in life-enhancing research that contributes profoundly to the public good. As mentors, they provide numerous undergraduate and graduate research opportunities, inspiring students to advance their skills and aspirations.

Students take advantage of more than 600 study abroad opportunities in more than 50 countries through UAlbany and SUNY's networks. These are valuable opportunities for young scholars to enhance their education, increase independence and self-awareness, and gain international experience that prepares them for today's global marketplace.

The varied perspectives and life experiences of a student body and faculty which represent 48 states and 96 countries provide a diversity that enriches learning at UAlbany.

The excellence of a UAlbany education is recognized by many independent sources, such as the rankings published yearly by U.S. News and World Report. Its great value results from the world of opportunities that are available to students at an affordable price.

The University's location in the state capital of New York provides students with limitless opportunities for internships and public service through which they gain experience, test their skills, and prepare to launch brilliant careers. The region is also a vibrant center for culture and entertainment. Among its attractions are the New York State Museum and Library and the Times Union Center, a major Northeast entertainment and sports venue. Close by are the Berkshires, the Catskills, Saratoga, and the Adirondack Mountains, areas famed for recreational and cultural opportunities.

Dr. Jeffrey Lombardo is the executive patient safety officer for UB’s patient safety organization Empire State Patient Safety Assurance Network. In this role he facilitates organization participation, logistics and implementation with participating sites as well as reviewing data and presenting reports on findings. Working with CCS Oncology he is tracking patient outcomes and advising physicians on best practices for cancer patients making full use of his specialty pharmacy certification in oncology. Dr. Lombardo is also a member of the SUNY Global Health Institute where he will be bringing his patient safety and oncology expertise to partner schools like the University of the West Indies for various collaborations. In Jamaica he will be partnering with Citivia Medical for studies on medical marijuana and pursuing new initiatives for the University at Buffalo’s medication management research network. (MMRN)

Dr. Lombardo received his Doctorate in Pharmacy from the University at Buffalo where he currently holds a Research Assistant Professor Title. He has completed research and co-authored several articles on topics involving chemotherapy in the field of solid tumors. Dr. Lombardo has worked in various cancer pharmacies throughout Western New York as well a national oncology specialty pharmacy. These roles provided Dr. Lombardo with expertise in contracting with managed care plans and companies in the pharmaceutical industry. In addition to these accomplishments Dr. Lombardo has exhibited and presented his work at the American Society of Clinical Oncology, American Society of Health System Pharmacists and Value Based Cancer Care Symposiums.

UB is a premier, research-intensive public university and a member of the Association of American Universities. As the largest, most comprehensive institution in the 64-campus State University of New York system, our research, creative activity and people positively impact the world. 

As a SUNY Distinguished Professor and Associate Director of the New York State Center of Excellence in Bioinformatics and Life Sciences, Dr. Morse has extensive experience in coordinating and governing multidisciplinary research efforts involving health information technology to improve patient safety. Dr. Morse also directs the Empire State Patient Safety Assurance Network, an AHRQ-designated, federally certified Patient Safety Organization and has led the UB 2020 effort to develop a model for statewide medication management programs in partnership with the NYS Department of Health Patient Safety Center. Dr. Morse has also worked with UB to establish the ESPSAN as a component of the UB 2020 planning process, a program that includes the School of Pharmacy and Pharmaceutical Sciences, Nursing, Medicine and Public Health. He also developed the UB Pharmacotherapy Information Center (PIC) and has led an effort to develop model medication management programs in Western New York and established the regional HIV Adherence-Pharmacology Program. Dr. Morse is also Co-Director of the UNYTE Translational Research Network of the University of Rochester CTSI, regional network composed of 18 academic and research institutions. In addition, Dr. Morse is the Director of the Translational Pharmacology Research Core in the New York State Center of Excellence in Bioinformatics and Life Sciences. Dr. Morse also holds appointments as a Professor in the Department of Pharmacy Practice, and Research Professor of Medicine and Pediatrics, at the University at Buffalo. Dr. Morse was previously the Associate Dean of Clinical and Translational Research in the School of Pharmacy and Pharmaceutical Sciences at the University at Buffalo.

VentriNova is a regenerative medicine company focused on reversing cardiac damage by activation of intrinsic repair pathways to generate de novo heart muscle cells. VentriNova’s first generation product is a gene therapy that delivers a critical mitotic regulator to diseased heart tissue to stimulate proliferation of cardiac muscle cells.

• No technology on the market or in clinical development, including stem cell-based technologies and other regenerative medicine applications, has the ability to grow new heart muscle cells in the diseased heart.

• VentriNova’s pioneering science and technology is centered on development of biologic and small molecule regulators of the cyclin A2 gene – the key switch mediating heart cell division.

• VentriNova’s technology demonstrated in both small and large animals the ability to control the modulation (increased gene expression) of the cyclin A2 gene, therefore stimulating endogenous growth of new myocytes (heart muscle cells).

• VentriNova’s VN-100 technology is the conductor that orchestrates existing human heart
  cells to divide and regenerate themselves – a cellular function that is silenced in early human development.